Skip to main content
Clinical Trials/NCT06353074
NCT06353074
Completed
Not Applicable

Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Atony

Necmettin Erbakan University1 site in 1 country16 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Uterine Atony With Hemorrhage
Sponsor
Necmettin Erbakan University
Enrollment
16
Locations
1
Primary Endpoint
Postpartum hysterectomy and/or intensive care unit need ratio
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study is aimed to show effectiveness of a new suture technique to stop postpartum uterine bleeding due to uterine atony.

Detailed Description

A retrospective study of all women received Acar's uterine compressive atony suture between January 2021-November 2023 at a single tertiary hospital with approximately 4000 deliveries per year, was performed. The local protocol for PPH due to uterine atony is uterine manual compression, 20 IU of intravenous oxytocin in 500 cc of normal saline at 500 cc/h; 800 µg of misoprostol inserted per rectal. If additional treatment is needed, carbetocin 100mcg in 100 cc of normal saline or tranexamic acid in different posologies are used. If uterine atony persists, intrauterine balloon tamponade or uterine compressive sutures were applied at the discretion of the physician and according to mode of delivery. When uterine compressive suture was performed, original Acar's atony suture was applied.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
November 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Cemre Alan

Fellow of Gynecologic Oncology

Necmettin Erbakan University

Eligibility Criteria

Inclusion Criteria

  • women without systemic disease

Exclusion Criteria

  • cardiac disease
  • rheumatological disease

Outcomes

Primary Outcomes

Postpartum hysterectomy and/or intensive care unit need ratio

Time Frame: Since first operation to discharge from hospital assessed up to 5 days

The need for hysterectomy or massive transfusion because of unstoppable and mortal bleeding

Study Sites (1)

Loading locations...

Similar Trials